XOMA Announces Closing of the Offering and Exercise of Over-Allotment Option Aug 23, 2013 12:12pm EDT
XOMA Highlights Recent Achievements and Reports Financial Results for Second Quarter 2013 Aug 07, 2013 4:01pm EDT
XOMA to Announce Second Quarter 2013 Financial Results and Host Webcast on August 7 Jul 25, 2013 9:00am EDT
XOMA Completes Enrollment in Phase 2 Proof-of-Concept Gevokizumab Trial in Patients With Erosive Osteoarthritis of the Hand Jul 22, 2013 8:00am EDT
XOMA's Development Partner SERVIER Launches Proof-of-Concept Clinical Program for Gevokizumab Jun 25, 2013 9:00am EDT
